- Home
- CASI vs HHS Comparison
CASI vs HHS Comparison
Compare CASI & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- HHS
- Stock Information
- Founded
- CASI 1991
- HHS 1923
- Country
- CASI China
- HHS United States
- Employees
- CASI N/A
- HHS N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- CASI Health Care
- HHS Consumer Discretionary
- Exchange
- CASI Nasdaq
- HHS Nasdaq
- Market Cap
- CASI 29.0M
- HHS 30.3M
- IPO Year
- CASI 1996
- HHS N/A
- Fundamental
- Price
- CASI $1.33
- HHS $3.83
- Analyst Decision
- CASI Strong Buy
- HHS
- Analyst Count
- CASI 1
- HHS 0
- Target Price
- CASI $4.00
- HHS N/A
- AVG Volume (30 Days)
- CASI 287.9K
- HHS 10.9K
- Earning Date
- CASI 08-15-2025
- HHS 08-07-2025
- Dividend Yield
- CASI N/A
- HHS N/A
- EPS Growth
- CASI N/A
- HHS N/A
- EPS
- CASI N/A
- HHS N/A
- Revenue
- CASI $31,368,000.00
- HHS $181,355,000.00
- Revenue This Year
- CASI N/A
- HHS $6.54
- Revenue Next Year
- CASI N/A
- HHS N/A
- P/E Ratio
- CASI N/A
- HHS N/A
- Revenue Growth
- CASI 8.39
- HHS N/A
- 52 Week Low
- CASI $1.10
- HHS $3.60
- 52 Week High
- CASI $7.67
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- CASI 28.60
- HHS 32.77
- Support Level
- CASI $1.10
- HHS $3.85
- Resistance Level
- CASI $2.07
- HHS $4.40
- Average True Range (ATR)
- CASI 0.28
- HHS 0.28
- MACD
- CASI -0.06
- HHS -0.04
- Stochastic Oscillator
- CASI 12.36
- HHS 16.43
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.